Benzonatate Capsules
Superpotent drug: Assay results were slightly above specification at the time zero point.
Yes — there is an active recall. 1 ongoing FDA recall mention Benzonatate (7 total). Check the affected lots below.
Most common reason: Failed specification (3 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Benzonatate. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Superpotent drug: Assay results were slightly above specification at the time zero point.
Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.
Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.
Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.